| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 308,891 | 304,641 | 306,175 | 327,912 | | Cost of Revenue | 185,591 | 220,239 | 211,156 | 280,068 | | | Gross Profit | 123,300 | 84,402 | 95,019 | 47,844 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 99,216 | 94,880 | 110,823 | 140,692 | | Non Recurring | 1,709 | 2,887 | 6,415 | 7,914 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,375 | (13,365) | (22,219) | (100,762) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34 | 36 | 183 | 53 | | Earnings Before Interest And Taxes | 22,409 | (13,329) | (22,036) | (100,709) | | Interest Expense | 7,236 | 7,245 | 7,355 | 5,083 | | Income Before Tax | 15,173 | (20,574) | (29,391) | (105,792) | | Income Tax Expense | (291) | (93) | (10,573) | 25,521 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,464 | (20,481) | (18,818) | (131,313) | | | Non-recurring Events | | Discontinued Operations | (911) | (4,003) | (4,752) | (230,220) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,553 | (24,484) | (23,570) | (361,533) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,553 | ($24,484) | ($23,570) | ($361,533) |
|
0.03% Nasdaq 
Income Statement
